| Position | Action |
|---|---|
| Current portfolio weight capped at 5-7% | Maintain current size |
| Daily close above 162.55 with above-average volume | Add up to 25% toward Overweight |
| Daily close below 146.37 (50-SMA) | Trim 30-50% toward Underweight |
| Price reaches 200-SMA at 138.26 | Only logical re-entry candidate |
ExxonMobil represents a generational opportunity in the #1 earnings-growth sector, combining a fortress balance sheet ($254B equity), record production, 79% forward earnings growth, and 5.7% effective yield at a discounted forward multiple—all while political and oil price risks are significantly overstated.
| Indicator | Value | Signal |
|---|---|---|
| 10-EMA | 153.93 | bullish |
| 50-SMA | 146.37 | bullish |
| 200-SMA | 138.26 | bullish |
| RSI (14) | 62.19 | bullish |
| MACD | +3.52 | bullish |
| MACD Signal | +2.81 | bullish |
| MACD Histogram | +0.70 | neutral |
| Bollinger Middle (20 SMA) | 149.35 | bullish |
| Bollinger Upper Band | 162.57 | bearish |
| Bollinger Lower Band | 136.13 | bullish |
| ATR (14) | 3.69 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Hold XOM in the 146.37-162.55 no-action zone pending Q3 earnings catalyst
Maintain XOM at current size within the 146.37-162.55 no-action zone; do not add until confirmed daily close above 162.55 with volume, targeting 170 then 180; trim 30-50% on breakdown below 146.37 with 138.26 as sole re-entry. Hold reflects balanced evidence: Q2's $14.5B profit and intact technicals prevent Underweight, while Q1 FCF collapse and unbroken resistance prevent Overweight. Q3 earnings in October is the next binary catalyst.
When: Daily close below 146.37 (50-SMA)
Then: Trim 30-50% toward Underweight
· concedes: Single quarter FCF softness is acknowledged (Q1 2026 FCF of $2.24B vs ~$9.2B capital return), though TTM FCF of $20.67B is the relevant figure; Net debt rising from $20.5B to $39.2B is real, though still less than 10% of total assets and 16% of equity; TTM P/E of 26x appears elevated, though Forward P/E of 14.6x signals recovery; Geopolitical and political risks exist but are historically overblown and already priced in at low probability (4% war probability)
XOM is a distribution setup at a cyclical peak — paying 26x TTM P/E for a war-aided quarter with deteriorating cash flows, rising political risk, and a stock that has failed to break $162.55 resistance for 11 weeks.
· concedes: Q2 $14.5B profit and 20-year production high are real numbers; MA structure is technically bullish (price above all MAs); Forward P/E of 14.6x would be attractive at normalized earnings; Beta of 0.17 provides diversification benefit in a portfolio context
→ vs conservative: 91% net debt jump is accounting optics from refinancing ($9.97B new debt issued to retire $5.56B), not credit deterioration; XOM has $254B equity, $482B retained earnings, <20% D/E, A-rated
→ vs neutral: Wait-and-see posture misses the recovery already here (Q2 $14.5B profit, 20-year production highs); earnings inflection imminent with 79% gap between $5.94 trailing and $10.64 forward EPS
→ vs neutral: Technical pattern is bull flag consolidation (10-EMA 153.93 support), not topping; two rejections at 162.55 are pre-breakout digestion before measured move to 180+
| neutral |
| VWMA | 152.53 | bullish |
Support: 153.93 · 149.35 · 146.37 · 141.69 · 138.26 · 136.13 | Resistance: 157 · 162.55 · 170.31
XOM technical analysis shows a structurally bullish long-term trend with all major moving averages stacked positively and price 12.1% above the 200-SMA. The stock is currently consolidating in a flag pattern between 153-157 after recovering 12.5% from the June low of 137.81 to current levels of 155.06. Momentum indicators are constructive but cooling: RSI has pulled back from overbought 72 to a healthy 62, while MACD remains positive at +3.52 but showing decelerating histogram. Key resistance sits at 162.57 (May high/upper Bollinger), with immediate support at 153.93 (10-EMA). The overall trading recommendation is HOLD for existing positions with a bias to add on pullbacks to 150-153 or breakout above 157 on volume expansion.
Market Cap
$642.7 billion
Beta
0.173
Shares Outstanding
4.14 billion
P/E (TTM)
26.10x
Forward P/E
14.57x
PEG Ratio
1.32
P/B
2.46x
EPS (TTM)
$5.94
Forward EPS
$10.64
Dividend Yield
2.65%
52-Week Range
$105.53 – $176.41
50-Day MA
$146.40
200-Day MA
$139.16
Gross Profit (TTM)
$107.5B
Gross Margin
29.8%
EBITDA (TTM)
$67.9B
Operating Margin
15.86%
Profit Margin
9.07%
ROE
12.58%
ROA
5.52%
Revenue 2025
$323.9B
Net Income 2025
$28.84B
Diluted EPS 2025
$6.70
EBITDA 2025
$67.86B
Revenue 2024
$339.2B
Net Income 2024
$33.68B
Diluted EPS 2024
$7.84
EBITDA 2024
$73.31B
Revenue 2023
$334.7B
Net Income 2023
$36.01B
Diluted EPS 2023
$8.89
EBITDA 2023
$74.27B
Revenue 2022
$398.7B
Net Income 2022
$55.74B
Diluted EPS 2022
$13.26
EBITDA 2022
$102.59B
Q1 2026 Revenue
$83.16B
Q1 2026 Operating Cash Flow
$8.71B
Q1 2026 CapEx
$6.47B
Q1 2026 Free Cash Flow
$2.24B
Q1 2026 Dividends
$4.33B
Q1 2026 Buybacks
$4.87B
TTM Free Cash Flow
$20.67B
Total Assets (Q1 2026)
$464.4B
Stockholders' Equity
$254.4B
Total Debt
$47.7B
Net Debt
$39.2B
Cash & Equivalents
$8.4B
Working Capital
$3.4B
Current Ratio
1.135
Debt/Equity
15.9%
Net PP&E
$298B
Treasury Stock (cumulative)
$263.3B
Strengths
Concerns
ExxonMobil is a mega-cap integrated oil major ($642.7B market cap) with strong fundamentals including a fortress balance sheet ($254.4B equity, 15.9% D/E) and industry-leading capital return program (2.65% dividend + ~$20B/year buybacks). However, the company faces cyclical headwinds with Q1 2026 operating income down 46% YoY, and there's a critical red flag: quarterly capital returns of ~$9.2B exceed FCF of $2.24B, forcing debt-funded buybacks. Net debt nearly doubled year-over-year to $39.2B. The market is pricing in a significant recovery with Forward P/E of 14.6x vs. TTM P/E of 26.1x, implying 79% EPS growth to $10.64. Best suited for income-focused and defensive investors with a 12-24 month horizon awaiting commodity price normalization.